Association of social deprivation with survival in younger adult patients with AML: an Alliance study

TY - JOUR

T1 - Association of social deprivation with survival in younger adult patients with AML

T2 - an Alliance study

AU - Rebechi, Melanie

AU - Kohlschmidt, Jessica

AU - Mrózek, Krzysztof

AU - Nicolet, Deedra

AU - Mims, Alice S.

AU - Blachly, James S.

AU - Orwick, Shelley

AU - Larkin, Karilyn T.

AU - Oakes, Christopher C.

AU - Hantel, Andrew

AU - Carroll, Andrew J.

AU - Blum, William G.

AU - Powell, Bayard L.

AU - Uy, Geoffrey L.

AU - Stone, Richard M.

AU - Larson, Richard A.

AU - Byrd, John C.

AU - Paskett, Electra D.

AU - Plascak, Jesse J.

AU - Eisfeld, Ann Kathrin

N1 - Funding Information: Acknowledgments: This study celebrates the life and accomplishments of Clara D. Bloomfield (1942-2020), who died unexpectedly on 1 March 2020. The authors are grateful to the patients who consented to participate in these clinical trials and the families who supported them; to Christopher Manring and the CALGB/Alliance Leukemia Tissue Bank at The Ohio State University Comprehensive Cancer Center, Columbus, OH, for sample processing and storage services; and to Lisa J. Sterling for data management. Research reported in this publication was supported by an allocation of computing resources from The Ohio Supercomputer Center and Shared Resources (Leukemia Tissue Bank). Research reported in this publication was supported, in part, by the National Cancer Institute of the National Institutes of Health under award numbers U10CA180821, U10CA180882, and U24CA196171 (to the Alliance for Clinical Trials in Oncology), UG1CA189824, UG1CA233338, UG1CA233339, P50 CA140158, UG1CA233331, UG1CA233180, R35CA197734, UG1CA189850, UG1CA233327, and 5P30CA016058; the Coleman Leukemia Research Foundation; ASH Junior Faculty Scholar and ASH Bridge award (A.-K.E.); the Leukemia & Lymphoma Society Translational Research Grant (A.-K.E.); The Leukemia Research Foundation (A.-K.E.); the National Comprehensive Cancer Network Foundation Young Investigator Award (J.S.B.); the Alliance for Clinical Trials in Oncology Scholar Award (J.S.B.); The D. Warren Brown Foundation; Pelotonia (A.-K.E. and A.S.M.). Support to Alliance for Clinical Trials in Oncology and Alliance Foundation Trials programs is listed at https://acknowledgments.alliancefound.org. Trial registration numbers are NCT00048958, NCT00899223, and NCT00900224. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: This study celebrates the life and accomplishments of Clara D. Bloomfield (1942-2020), who died unexpectedly on 1 March 2020. The authors are grateful to the patients who consented to participate in these clinical trials and the families who supported them; to Christopher Manring and the CALGB/Alliance Leukemia Tissue Bank at The Ohio State University Comprehensive Cancer Center, Columbus, OH, for sample processing and storage services; and to Lisa J. Sterling for data management. Research reported in this publication was supported by an allocation of computing resources from The Ohio Supercomputer Center and Shared Resources (Leukemia Tissue Bank). Research reported in this publication was supported, in part, by the National Cancer Institute of the National Institutes of Health under award numbers U10CA180821, U10CA180882, and U24CA196171 (to the Alliance for Clinical Trials in Oncology), UG1CA189824, UG1CA233338, UG1CA233339, P50 CA140158, UG1CA233331, UG1CA233180, R35CA197734, UG1CA189850, UG1CA233327, and 5P30CA016058; the Coleman Leukemia Research Foundation; ASH Junior Faculty Scholar and ASH Bridge award (A.-K.E.); the Leukemia & Lymphoma Society Translational Research Grant (A.-K.E.); The Leukemia Research Foundation (A.-K.E.); the National Comprehensive Cancer Network Foundation Young Investigator Award (J.S.B.); the Alliance for Clinical Trials in Oncology Scholar Award (J.S.B.); The D. Warren Brown Foundation; Pelotonia (A.-K.E. and A.S.M.). Support to Alliance for Clinical Trials in Oncology and Alliance Foundation Trials programs is listed at https://acknowledgments.alliancefound.org. Trial registration numbers are NCT00048958, NCT00899223, and NCT00900224. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2023/8/8

Y1 - 2023/8/8

UR - https://www.scopus.com/pages/publications/85169800988

U2 - 10.1182/bloodadvances.2022009325

DO - 10.1182/bloodadvances.2022009325

M3 - Letter

C2 - 37196637

AN - SCOPUS:85169800988

SN - 2473-9529

VL - 7

SP - 4019

EP - 4023

JO - Blood Advances

JF - Blood Advances

IS - 15

ER -